Government News

- Read more about New health era will begin in India with National Digital Health Blueprint
The National Health Policy 2017 had defined the vision of ‘health and wellbeing for all at all ages’. Continuum of Care is a concept strongly advocated by the Policy. These lofty ideals are sought to be achieved by refactoring the existing schemes and introducing several new schemes including some digital initiatives.
11 July 2019

Patients saved more than 12000 crores after Price Fixation by Government

As per government report, patients have saved Rs. 12,447 crores after Price Fixation of Essential Medicines by National Pharmaceutical Pricing Authority (NPPA). NPPA is an independent Regulator for pricing of drugs and to ensure availability and accessibility of medicines at affordable prices.
- Read more about Dr. Harsh Vardhan: Union Budget has strengthened the health sector with 154.87% increase for Ayushman Bharat, and 18.67% increase in overall outlay
“The General Budget 2019-20 is a reflection of the pragmatism and visionary governance of our Prime Minister Shri Narendra Modiji. It is development-oriented and people-centric.A landmark budget was presented today by the Finance Minister Smt. Nirmala Sitharaman with the agenda of “putting the nation first”. This was stated by Dr. Harsh Vardhan, Union Minister for Health and Family Welfare while welcoming the Union Budget for the year 2019-20. Thanking the Prime Minister Shri Narendra Modiji and the Finance Minister, Dr Harsh Vardhan further said that this is an inclusive budget which is pro-poor, pro-farmer, pro-downtrodden and for the development of all the sectors and the country at large.
- Read more about Ministry of AYUSH signed MOU between with Ministry of Electronics and Information Technology
Ministry of AYUSH (MOA) and Ministry of Electronics and Information Technology (MeitY) have signed MOU at New Delhi for collaborating with each other for digitization of AYUSH Sector. MeitY has agreed to advise and give technical support to MOA for planning and development of AYUSH GRID Project.
11 June 2019

ePharmacy is looking towards health profession as business : AIOCD

The E-Pharmacy is an off-shoot of modern technology. The benefits of internet pharmacies propagated are convenience; allow the door delivery of drugs at low cost, but the picture presented is misleading and hiding the facts, says All India Organisation of Chemists and Druggists (AIOCD) as a objection towards ePharmacy working in India.
- Read more about CCI imposes penalty on Chemists and Druggists Association and Pharmaceutical Companies
The Competition Commission of India (‘Commission’) has found Madhya Pradesh Chemists and Druggist Association (‘MPCDA’), Indore Chemists Association (‘ICA’), Himalaya Drug Company (‘HDC’) and Intas Pharmaceuticals Limited (‘IPL’) along with some of their office bearers/officials to be in contravention of the provisions of the Competition Act, 2002 (‘Act’).
30 May 2019

IMA strongly opposes move by PCI to use Dr prefix for Pharm.D

Pharmacy Council of India has reportedly directed universities to use the prefix 'Doctor (Dr)' while awarding degrees to Pharm.D graduates. Indian Medical Association strongly opposes any move from those who are trained in other streams of Health sector to venture into medical practice.
- Read more about US filed lawsuits against Indian Pharmaceuticals over Price fixing
Connecticut Attorney General William Tong is leading a 44-state coalition in an antitrust lawsuit against 20 makers of generic drugs and 15 individuals, claiming the companies conspired to fix prices for 114 medications.
- Read more about IPA asks AIIMS not to violate recruitment rules of pharmacists
Indian Pharmacists Association (IPA) strictly opposes use of the post name Dispensing Attendant instead of Pharmacist for recent recruitment advertisement by AIIMS Rishikesh. As per IPA, the advertisement No. 2019/153 by AIIMS Rishikesh is violating Pharmacy Act and Drugs and Cosmetic rules.
- Read more about Indian have poor access to anticancer drugs : Study
Limited access to essential medicines for treating chronic diseases is a major challenge in low and middle-income countries. Although India is the largest manufacturer of generic medicines, there is a paucity of information on availability, price and affordability of essential anti-cancer medicines used for treating childhood cancers.